Description
CJC-1295 and Ipamorelin have been combined as a peptide blend because they share similar functional properties that allow them to work well together.
CJC-1295, when introduced to animal test subjects as part of a scientific study, affects the number of secreting cells and the amount of secretions they are able to express. It is chiefly responsible for providing a sense of homeostasis in relation to growth regulation. The introduction of this peptide allows for an increase in activity relating to a cell’s ability to express secretions as well as the amount of expressions that they are able to secrete. CJC-1295 is primarily able to perform this function because of its capability to extend its half-life. Scientific study based an animal test subjects have determined that this half-life can expand from less than seven minutes to more than seven days. Because of this lengthening, the functionality of the peptide in turn allows for a longer period of what the secretions can do within an animal test subject’s body. In this case, it is tied to the ability to synthesize proteins at an accelerated rate, which would then lead to more efficient bodily functions related to several endocrine system-related processes, including:
- Quicker rate of injury recovery
- Increase in bone density
- Stronger immune system
- More efficient growth of muscular tissue
